Brooke Tobia
Medical · Sterling Heights, MINPI 1568740918
Payments from drug & device makers
Across 982 payments — averaging $15.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$2K
- AbbVie$2K
- AstraZeneca$1K
- Amgen$1K
- Lilly USA, LLC$1K
- Pfizer$919
- plus $6K from 41 others
What the payments were for
- Food & beverage$14,906100%
- Education$300%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$14,936 in reported general payments places this provider in the 95th percentile of 755 medical providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 76 | $69,166 |
| RexultiBrexpiprazole | 20 | $52,263 |
| JardianceEmpagliflozin | 38 | $47,909 |
| TrulicityDulaglutide | 43 | $40,362 |
| EliquisApixaban | 27 | $31,568 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 102 | $25,769 |
| XareltoRivaroxaban | 17 | $22,442 |
| LinzessLinaclotide | 20 | $20,951 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 23 | $20,709 |
| SuboxoneBuprenorphine Hcl/Naloxone Hcl | 31 | $18,212 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 34 | $17,955 |
| Trijardy XrEmpaglifloz/Linaglip/Metformin | 27 | $17,319 |
| FarxigaDapagliflozin Propanediol | 13 | $16,380 |
| MounjaroTirzepatide | 14 | $13,270 |
| OxycontinOxycodone Hcl | 11 | $12,913 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $1,913 | $69,16676 claims |
| Boehringer IngelheimJardiance, Trijardy Xr | $443 | $65,22865 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $1,148 | $53,63157 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $15 | $52,26320 claims |
| PfizerEliquis, Abrysvo | $919 | $37,88847 claims |
| GSKTrelegy Ellipta, Shingrix | $355 | $24,06938 claims |
| Johnson & JohnsonXarelto | $82 | $22,44217 claims |
| AbbVieLinzess | $1,905 | $20,95120 claims |
| Indivior Inc.Suboxone | $80 | $18,21231 claims |
| AstraZenecaFarxiga | $1,445 | $16,38013 claims |
| Sanofi-aventis U.S. LLCLantus | $119 | $1,08114 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 755 medical providers in Michigan.
Other medical in Sterling Heights
- Caleb YoungbloodBerkley$215K
- Steven StoneKalamazoo$200K
- Meredith KentGrand Rapids$192K
- Amber ShullNorton Shores$154K
- Jason EvansWaterford$104K
- James ToreySaint Clair Shores$66K
- David WilkinsMuskegon$41K
- Mark RosenBerkley$32K
- Robert DemeesterRoyal Oak$27K
- John BrabantDetroit$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.